STING1 and cancer: Unfortunately, we are underpowered to detect it, so that we reasoned that these data could represent an assist for researchers interested in STING1 analysis and collecting clinical data spanning from cancer therapy with checkpoint inhibitors, oncolytic viruses (e.g., TVEC) and other immunotherapeutic regimens, to gene therapy with DNA viruses, infectious and autoimmune diseases56–64.